High density lipoprotein metabolism

Size: px
Start display at page:

Download "High density lipoprotein metabolism"

Transcription

1 High density lipoprotein metabolism

2 Lipoprotein classes and atherosclerosis Chylomicrons, VLDL, and their catabolic remnants Pro-atherogenic LDL HDL Anti-atherogenic

3 Plasma lipid transport Liver VLDL FC FC TG FFA TG LPL LDL FFA Adipose and other tissues Adipose tissue TP TG Liver LDL receptor LDL receptor Bile HDL TG LCAT ABCA1 FC New synthesis Cell in peripheral tissue

4 HDL and cardiovascular disease

5 Hazard Ratio Coronary heart disease and HDL-C N = 302,430 Adjusted for age and gender Adjusted for multiple factors HDL-C (mmol/l) The Emerging Risk Factors Collaboration. JAMA 2009;302:

6 What are HDLs?

7 Structure of HDL Surface monolayer of phospholipids and free cholesterol apoa-i apoa-ii Hydrophobic core of triglyceride and cholesteryl esters

8 HDL are heterogeneous COMPOSITION APOLIPOPROTEINS ApoA-I, apoa-ii, apoa-iv, apoe, others LIPIDS TG,, FC, PL SIZE: nm SHAPE: spherical, discoidal CHARGE: prebeta, alpha

9 HDL Charge and shape Lipid-poor apoa-i Prebeta mobility Discoidal Prebeta mobility Spherical Alpha mobility

10 HDL Subpopulations PARTICLE SHAPE APOLIPOPROTEIN COMPOSITION Discoidal Spherical A-I HDL A-I/A-II HDL PARTICLE SIZE Lipid-poor apoa-i HDL 2b HDL 2a HDL 3a HDL 3b HDL 3c

11 This HDL heterogeneity is the result of activity of several factors that assemble and remodel HDL in plasma

12 Origin of apoa-i LIVER INTESTINE Chylomicrons Lipid-poor apoa-i Lipolysis

13 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

14 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

15 Lipidation of apoa-i Lipid-poor apoa-i Cell membrane ABCA-1 phospholipid, cholesterol Discoidal HDL

16 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

17 LCAT (lecithin:cholesterol acyltransferase) LCAT catalyses the reaction: phosphatidylcholine lysophosphatidylcholine unesterified cholesterol cholesteryl ester

18 LCAT The LCAT reaction is responsible for most of the cholesteryl esters circulating in plasma HDLs are the preferred substrates for LCAT LCAT is activated by apoa-i, apoa-iv, apoe LCAT NOT activated by apoa-ii

19 Role of LCAT in formation of spherical HDL Liver Intestine Free cholesterol transferred from cell membranes (including liver and intestine) apoa-i free cholesterol LCAT cholesteryl esters Discoidal HDL Spherical HDL

20 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

21 Role of TP in plasma cholesterol transport Liver LDL-R SR-B1 FC SR-B1 TP VLDL/LDL Bile HDL LCAT FC Extrahepatic Tissues (including the artery wall Free Cholesterol

22 Shuttle mechanism HDL TP TP TRL TG TG TG TG TG TP TG TP TG LDL Barter et al; Biochem J. 1982; 208:1. Swenson et al. J. Biol. Chem. 1988; 263:5150. Tall. J. Lipid Res.1993; 34:1255.

23 TP plays a major role in remodelling of HDL, especially when acting in the presence of hepatic lipase

24 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

25 HEPATIC LIPASE Hepatic lipase catalyses the hydrolysis of triglyceride and phospholipids in HDL Remodelling of HDL by hepatic lipase is most dramatic when linked to activity of TP

26 Role of TP and hepatic lipase in the remodelling of HDL HDL TGR-LP TG TP TG HDL TG Lipid-free/poor apoa-i TG HL FFA TG Excretion through kidney Small, dense HDL Rye et al Atherosclerosis, 1999,145:227 Rye et al Arterioscler Thromb Vasc Biol, 2004, 24: 421.

27 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

28 PLTP (phospholipid transfer protein) PLTP catalyses the transfer of phospholipids between plasma lipoproteins PLTP also remodels HDL

29 Remodelling of AI-HDL by PLTP PLTP PLTP PLTP lipid-poor apoa-i

30 Factors that assemble and remodel HDL in plasma ABCA1 LCAT TP Hepatic lipase PLTP SRB1

31 SRB1 (scavenger receptor type B1) SRB1 promotes the selective hepatic uptake of HDL cholesteryl esters SRB1 thus also remodels HDL

32 Remodelling of AI-HDL by SRB1 Liver Lipid-poor apoa-i SRB1 TG Larger HDL TG Smaller HDL

33 Apolipoprotein-specific HDL apoa-i apoa-i TG TG apoa-ii Spherical AI-HDL Spherical AI/AII-HDL

34 Origin of AII-HDL Secretion LIVER Lipid-poor apoa-ii phospholipids from cell membranes Discoidal AII-HDL

35 LCAT-mediated formation of spherical AI/AII-HDL Discoidal AI-HDL LCAT Spherical AI-HDL LCAT Fusion Spherical AI/AII-HDL TG LIVER Discoidal AII-HDL

36 Remodelling of HDL generates lipid-poor apoa-i

37 Remodelling of HDL generates lipid-poor apoa-i TG TP HL PLTP SRB1 TG Lipid-poor apoa-i

38 Fate of lipid-poor apoa-i Lipid-poor apoa-i Acquire PL from cells (via ABCA1) to form discoidal HDL Discoidal AI-HDL Incorporation into spherical AI-HDL Excretion through kidney Small, spherical AI-HDL LCAT Large, spherical AI-HDL

39 Cycling of apoa-i between HDL and a HDL TP HL PLTP SRB1 TG lipid-poor pool Lipid-poor apoa-i Excretion through kidney Discoidal HDL TG UC LCAT TG

40 Functions of HDL

41 Role of HDL in promoting efflux of cholesterol from cells

42 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i ABCA1 FC,PL

43 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i ABCA1 FC,PL Discoidal HDL

44 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL ABCA1 ABCA1 SR-B1 FC,PL FC

45 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT ABCA1 ABCA1 SR-B1 FC,PL FC Small spherical HDL

46 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT ABCA1 ABCA1 SR-B1 FC,PL FC Small spherical HDL Diffusion SR-B1 ABCG1 FC

47 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT Small spherical HDL LCAT ABCA1 ABCA1 SR-B1 Diffusion SR-B1 ABCG1 FC,PL FC FC Larger spherical HDL

48 Efflux of cholesterol from cells Extracellular space Cell membrane Lipid-poor apoa-i Discoidal HDL LCAT Small spherical HDL LCAT ABCA1 ABCA1 SR-B1 Diffusion SR-B1 ABCG1 FC,PL FC FC Larger spherical HDL Diffusion SR-B1 ABCG1 FC

49 Protective properties of HDLs Promote cholesterol efflux from macrophages Anti-oxidant properties Anti-thrombotic properties Anti-inflammatory properties Improve endothelial function Promote endothelial repair Improve glycemic control Other

50 Conclusions The concentration of HDL-C correlates inversely with CV risk

51 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect

52 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment

53 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment The HDL fraction in human plasma is heterogeneous in terms of particle size, charge and composition

54 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment The HDL fraction in human plasma is heterogeneous in terms of particle size, charge and composition HDL particles are extensively remodelled in plasma by a variety of proteins and enzymes

55 Conclusions The concentration of HDL-C correlates inversely with CV risk HDL particles have many properties with the potential to protect HDL particles are assembled in the plasma compartment The HDL fraction in human plasma is heterogeneous in terms of particle size, charge and composition HDL particles are extensively remodelled in plasma by a variety of proteins and enzymes Deficiencies of these remodelling factors result in major changes to HDL particles

56 Unanswered questions Q. Which HDL subpopulations (if any) protect against CV disease? Answer: We do not know Q. Which (if any) of the known HDL functions protect against CV disease? Answer: We do not know Answers to these questions require much more research

Lipid/Lipoprotein Structure and Metabolism (Overview)

Lipid/Lipoprotein Structure and Metabolism (Overview) Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter President, International Atherosclerosis Society Centre for Vascular Research University of New South Wales Sydney, Australia Disclosures

More information

Lipoproteins Metabolism

Lipoproteins Metabolism Lipoproteins Metabolism LEARNING OBJECTIVES By the end of this Lecture, the student should be able to describe: What are Lipoproteins? Describe Lipoprotein Particles. Composition of Lipoproteins. The chemical

More information

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry Learning Objectives 1. Define lipoproteins and explain the rationale of their formation in blood. 2. List different

More information

ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism

ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism I. Chylomicrons (exogenous pathway) A. 83% triacylglycerol, 2% protein, 8% cholesterol plus cholesterol esters, 7% phospholipid (esp. phosphatidylcholine)

More information

Chapter VIII: Dr. Sameh Sarray Hlaoui

Chapter VIII: Dr. Sameh Sarray Hlaoui Chapter VIII: Dr. Sameh Sarray Hlaoui Lipoproteins a Lipids are insoluble in plasma. In order to be transported they are combined with specific proteins to form lipoproteins: Clusters of proteins and lipids.

More information

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:

More information

Pathophysiology of Lipid Disorders

Pathophysiology of Lipid Disorders Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history

More information

Lipids digestion and absorption, Biochemistry II

Lipids digestion and absorption, Biochemistry II Lipids digestion and absorption, blood plasma lipids, lipoproteins Biochemistry II Lecture 1 2008 (J.S.) Triacylglycerols (as well as free fatty acids and both free and esterified cholesterol) are very

More information

CETP inhibition: pros and cons. Philip Barter The Heart Research Institute Sydney, Australia

CETP inhibition: pros and cons. Philip Barter The Heart Research Institute Sydney, Australia CETP inhibition: pros and cons Philip Barter The Heart Research Institute Sydney, Australia Philip Barter Disclosures Received honorariums for lectures, consultancies or membership of advisory boards from:

More information

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien

More information

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema

The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema The inhibition of CETP: From simply raising HDL-c to promoting cholesterol efflux and lowering of atherogenic lipoproteins Prof Dr J Wouter Jukema Dept Cardiology, Leiden University Medical Center, Leiden,

More information

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins - Cholesterol: It is a sterol which is found in all eukaryotic cells and contains an oxygen (as a hydroxyl group OH) on Carbon number

More information

Glossary For TheFatNurse s For All Ages Series Adipocytes, also known as lipocytes and fat cells, are the cells that primarily compose adipose tissue, specialized in storing energy as fat. Apolipoprotein

More information

LIPOPROTEINE ATEROGENE E ANTI-ATEROGENE ATEROGENE

LIPOPROTEINE ATEROGENE E ANTI-ATEROGENE ATEROGENE LIPOPROTEINE ATEROGENE E ANTI-ATEROGENE ATEROGENE Sebastiano Calandra Dipartimento di Scienze Biomediche Università di Modena e Reggio Emilia Incidence Rate/1000 200-150 - 100-50 - Women 0 Men

More information

Acetyl CoA HMG CoA Mevalonate (C6) Dimethylallyl Pyrophosphate isopentenyl Pyrophosphate (C5) Geranyl Pyrophosphate (C10) FarnesylPyrophosphate (C15) Squalene (C30) Lanosterol (C30) 7 Dehydrocholesterol

More information

Nature Genetics: doi: /ng.3561

Nature Genetics: doi: /ng.3561 Supplementary Figure 1 Pedigrees of families with APOB p.gln725* mutation and APOB p.gly1829glufs8 mutation (a,b) Pedigrees of families with APOB p.gln725* mutation. (c) Pedigree of family with APOB p.gly1829glufs8

More information

HDL : A Treatment Target? ESC Paris M. John Chapman Ph.D., D.Sc., FESC. President, European Atherosclerosis Society

HDL : A Treatment Target? ESC Paris M. John Chapman Ph.D., D.Sc., FESC. President, European Atherosclerosis Society ESC Paris 2011 HDL : A Treatment Target? M. John Chapman Ph.D., D.Sc., FESC Director, Dyslipidemia and Atherosclerosis Research Unit, INSERM, University Pierre and Marie Curie, Hôpital de la Pitié-Salpetriere,

More information

Metabolism and Atherogenic Properties of LDL

Metabolism and Atherogenic Properties of LDL Metabolism and Atherogenic Properties of LDL Manfredi Rizzo, MD, PhD Associate Professor of Internal Medicine Faculty of Medicine, University of Palermo, Italy & Affiliate Associate Professor of Internal

More information

Cholesterol Metabolism

Cholesterol Metabolism Cholesterol Metabolism Lippincott s Illustrated Review Chapter 18 Steroid Nucleus 1 2 Cholesterol was isolated from gall bladder stones in 1774 3 Sources and Elimination of Cholesterol Synthesis: 1000

More information

Plasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam

Plasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam Biochemistry Department Plasma lipoproteins & atherosclerosis by Prof.Dr. Maha M. Sallam 1 1. Recognize structures,types and role of lipoproteins in blood (Chylomicrons, VLDL, LDL and HDL). 2. Explain

More information

Regulating Hepatic Cellular Cholesterol

Regulating Hepatic Cellular Cholesterol Under circumstances of cholesterol deficiency, Sterol Regulatory Element Binding Proteins (SREBPs) via binding to DNA nuclear response elements set off genomic production of proteins and enzymes that induce

More information

Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors

Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors Atherosclerosis Supplements 3 (2002) 39/47 www.elsevier.com/locate/atherosclerosis Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors P.J. Barter Hanson Institute, Adelaide,

More information

Summary and concluding remarks

Summary and concluding remarks Summary and concluding remarks This thesis is focused on the role and interaction of different cholesterol and phospholipid transporters. Cholesterol homeostasis is accomplished via a tightly regulated

More information

Niacin Metabolism: Effects on Cholesterol

Niacin Metabolism: Effects on Cholesterol Niacin Metabolism: Effects on Cholesterol By Julianne R. Edwards For Dr. William R. Proulx, PhD, RD Associate Professor of Nutrition and Dietetics In partial fulfillments for the requirements of NUTR342

More information

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries Lipid Disorders in Diabetes (Diabetic Dyslipidemia) Khosrow Adeli PhD, FCACB, DABCC Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University it of Toronto Diabetes A Global

More information

PPAR history of research

PPAR history of research PPAR Rubens, 1640 PPAR history of research number of publications 3000 2000 1000 0 till now: : 16 296 publications 1985 1990 1995 2000 2005 year liver, brown adipocytes, kidney, heart, skeletal muscles,

More information

Lipid Metabolism Prof. Dr. rer physiol. Dr.h.c. Ulrike Beisiegel

Lipid Metabolism Prof. Dr. rer physiol. Dr.h.c. Ulrike Beisiegel Lipid Metabolism Department of Biochemistry and Molecular Biology II Medical Center Hamburg-ppendorf 1 Lipids. visceral fat. nutritional lipids 0 1.5 3 4.5 9 h. serum lipids. lipid accumulation in the

More information

Chapter (5) Etiology of Low HDL- Cholesterol

Chapter (5) Etiology of Low HDL- Cholesterol Chapter (5) Etiology of Low HDL- Cholesterol The aim of this chapter is to summarize the different etiological factors mainly the role of life-style and different disease conditions contributing to the

More information

Lipoprotein Pathophysiology. Lipoprotein Pathophysiology

Lipoprotein Pathophysiology. Lipoprotein Pathophysiology Lipoprotein Pathophysiology Genetic Dyslipidemia Thomas A. Hughes, M.D. Professor of Medicine Division of Endocrinology, Metabolism, and Diabetes University of Tennessee Health Science Center GW is a 47

More information

Cholesterol and its transport. Alice Skoumalová

Cholesterol and its transport. Alice Skoumalová Cholesterol and its transport Alice Skoumalová 27 carbons Cholesterol - structure Cholesterol importance A stabilizing component of cell membranes A precursor of bile salts A precursor of steroid hormones

More information

Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes

Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes Atherosclerosis 137 Suppl. (1998) S13 S17 Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes Michael C. Phillips *, Kristin L. Gillotte, M. Page Haynes, William

More information

Cholesterol metabolism. Function Biosynthesis Transport in the organism Hypercholesterolemia

Cholesterol metabolism. Function Biosynthesis Transport in the organism Hypercholesterolemia Cholesterol metabolism Function Biosynthesis Transport in the organism Hypercholesterolemia - component of all cell membranes - precursor of bile acids steroid hormones vitamin D Cholesterol Sources: dietary

More information

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? Michael Davidson M.D. FACC, Diplomate of the American Board of Lipidology Professor,

More information

5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT

5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT 5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT Prof. Victor Blaton, Ph.D. Department of Clinical Chemistry, Hospital AZ Sint-Jan

More information

Lipid metabolism in familial hypercholesterolemia

Lipid metabolism in familial hypercholesterolemia Lipid metabolism in familial hypercholesterolemia Khalid Al-Rasadi, BSc, MD, FRCPC Head of Biochemistry Department, SQU Head of Lipid and LDL-Apheresis Unit, SQUH President of Oman society of Lipid & Atherosclerosis

More information

CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL

CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL You will notice that the endogenous pathway is very similar to the exogenous pathway What is the average daily amount of triacylglycerol

More information

STRUCTURE AND METABOLISM Of LIPIDS AND LIPOPROTEINS. R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty

STRUCTURE AND METABOLISM Of LIPIDS AND LIPOPROTEINS. R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty STRUCTURE AND METABOLISM Of LIPIDS AND LIPOPROTEINS R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty STRUCTURE OF LIPIDS AND LIPOPROTEINS DEFINTITION: Compounds Insoluble in water But

More information

Disclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017

Disclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017 Disclosures MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES Grants: NIH, Quest Diagnostics Consultant: Quest Diagnostics Merck Global Atherosclerosis Advisory Board Ronald M. Krauss, Children s Hospital

More information

Mendelian disorders refer to diseases caused by mutations. Review. Mendelian Disorders of High-Density Lipoprotein Metabolism

Mendelian disorders refer to diseases caused by mutations. Review. Mendelian Disorders of High-Density Lipoprotein Metabolism Review This Review is part of a thematic series on High-Density Lipoprotein, which includes the following articles: Mendelian Disorders of HDL Metabolism Regulation of High-Density Lipoprotein Metabolism

More information

N-3 Fatty Acids Non-HDL-Cand LDL-C Thomas Dayspring MD, FACP

N-3 Fatty Acids Non-HDL-Cand LDL-C Thomas Dayspring MD, FACP Omega or N-3 Fatty Acids (FA) significantly reduce TG synthesis and significantly deplete the TG content of VLDL particles indicated by significantly reduced V. FA are the substrate for TG synthesis. N3-FA

More information

The role of HDL-cholesterol in preventing atherosclerotic disease

The role of HDL-cholesterol in preventing atherosclerotic disease European Heart Journal Supplements (2005) 7 (Supplement F), F4 F8 doi:10.1093/eurheartj/sui036 The role of HDL-cholesterol in preventing atherosclerotic disease Philip Barter* The Heart Research Institute,

More information

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing

More information

HDL and Its Galaxy of Proteins: What Do they Do? Jay Heinecke, University of Washington

HDL and Its Galaxy of Proteins: What Do they Do? Jay Heinecke, University of Washington HDL and Its Galaxy of Proteins: What Do they Do? Jay Heinecke, University of Washington Disclosures NIH AHA Insilicos Consultant Merck Research Support GSK Research Support Pfizer Research Support Corcept

More information

ESC Congress 2011 Wednesday August 31st 2011

ESC Congress 2011 Wednesday August 31st 2011 ESC Congress 211 Wednesday August 31st 211 stimulates endothelial CAT-1 expression and L-arginine uptake: a novel mechanism leading to endothelial-protective effects of that is profoundly impaired in patients

More information

Contributions in Medicine: Will CETP Inhibition Contribute Toward Reduction of Cardiovascular Risk?

Contributions in Medicine: Will CETP Inhibition Contribute Toward Reduction of Cardiovascular Risk? Contributions in Medicine: Will TP Inhibition Contribute Toward Reduction of Cardiovascular Risk? Activity presentations are considered intellectual property. These slides may not be published or posted

More information

Supplemental Material. Results

Supplemental Material. Results Supplemental Material Results Fractionation of mouse plasma by high-resolution SEC. APOA1 eluted as a single major peak in fractions 16 of plasma (the apparent size of mature, lipidated HDL) when it was

More information

Hypertriglyceridemia. Ara Metjian, M.D. Resident s Report 20 December 2002

Hypertriglyceridemia. Ara Metjian, M.D. Resident s Report 20 December 2002 Hypertriglyceridemia Ara Metjian, M.D. Resident s Report 20 December 2002 Review of Lipids Chylomicrons (CM): Dietary lipids absorbed through the GI tract are assembled intracellularly into CM. Very Low

More information

Dipartimento di Scienze Cliniche Luigi Sacco SCUOLA DI DOTTORATO DI RICERCA IN SCIENZE BIOCHIMICHE, NUTRIZIONALI E METABOLICHE

Dipartimento di Scienze Cliniche Luigi Sacco SCUOLA DI DOTTORATO DI RICERCA IN SCIENZE BIOCHIMICHE, NUTRIZIONALI E METABOLICHE Dipartimento di Scienze Cliniche Luigi Sacco SCUOLA DI DOTTORATO DI RICERCA IN SCIENZE BIOCHIMICHE, NUTRIZIONALI E METABOLICHE DOTTORATO DI RICERCA IN NUTRIZIONE SPERIMENTALE E CLINICA CICLO XXIII TESI

More information

Lipid Metabolism in Familial Hypercholesterolemia

Lipid Metabolism in Familial Hypercholesterolemia Lipid Metabolism in Familial Hypercholesterolemia Khalid Al-Rasadi, BSc, MD, FRCPC Head of Biochemistry Department, SQU Head of Lipid and LDL-Apheresis Unit, SQUH President of Oman society of Lipid & Atherosclerosis

More information

Prof. John Chapman, MD, PhD, DSc

Prof. John Chapman, MD, PhD, DSc Prof. John Chapman, MD, PhD, DSc Director of the Dyslipidemia and Atherosclerosis Research Unit of the National Institute for Health and Medical Research (INSERM) at the Pitié-Salpétrière Hospital in Paris

More information

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Our laboratory focuses on the role of apolipoprotein (apo) B- containing lipoproteins in normal

More information

TC =96; HDL-C = 21; Non-HDL-C = 75; LDL-C: less than 10 TG: 357; VLDL-C = 71; TG/HDL-C: 17 TC/HDL-C = 4.5

TC =96; HDL-C = 21; Non-HDL-C = 75; LDL-C: less than 10 TG: 357; VLDL-C = 71; TG/HDL-C: 17 TC/HDL-C = 4.5 LIPID CASE 269 He said - she said?? I want to have some fun with this issue's case discussion. It was sent to me by a respected lipidologist who shared a case first seen by his nurse practitioner. They

More information

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,

More information

Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I

Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I Kerry-Anne Rye, Philip J. Barter Abstract The preferred extracellular acceptor of cell phospholipids and unesterified cholesterol

More information

Chapter 1 GENERAL INTRODUCTION. 1.1 Lipoproteins and Lipid Metabolism

Chapter 1 GENERAL INTRODUCTION. 1.1 Lipoproteins and Lipid Metabolism GENERAL INTRODUCTION Contents 1.1 Lipoproteins and lipid metabolism 1.2 Atherosclerosis 1.3 HDL and atherosclerosis 1.4 ABCA-transporters 1.5 Lipid transfer proteins: CETP and PLTP 1.6 Macrophage RCT pathway:

More information

Placental Transport in Pathologic Pregnancies

Placental Transport in Pathologic Pregnancies Note: for non-commercial purposes only Placental Transport in Pathologic Pregnancies Gernot Desoye Clinic of Obstetrics and Gynaecology Medical University, Graz Most Common Pregnancy Pathologies Diabetes

More information

Lipids, lipoproteins and cardiovascular disease

Lipids, lipoproteins and cardiovascular disease Lipids, lipoproteins and cardiovascular disease Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy Cardiovascular disease Plasma enzymes

More information

Zuhier Awan, MD, PhD, FRCPC

Zuhier Awan, MD, PhD, FRCPC Metabolism, Atherogenic Properties and Agents to Reduce Triglyceride-Rich Lipoproteins (TRL) The Fifth IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk Muscat, Oman, February 8-11, 2019 Zuhier

More information

review Cell cholesterol efflux: integration of old and new observations provides new insights

review Cell cholesterol efflux: integration of old and new observations provides new insights Cell cholesterol efflux: integration of old and new observations provides new insights review George H. Rothblat, 1, * Margarita de la Llera-Moya,* Veronique Atger, Ginny Kellner-Weibel,* David L. Williams,

More information

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC Hypertriglyceridemia: Why, When, and How to Treat Gregory Cohn, MD, FNLA, FASPC DISCLOSURES Consultant to Akcea Therapeutics (in the past 12 months). OUTLINE I. Lipoproteins II. Non-HDL-C III. Causes and

More information

Cholesterol efflux as a measure of HDL functionality in humans: impact of genetics, diet and weight loss

Cholesterol efflux as a measure of HDL functionality in humans: impact of genetics, diet and weight loss Cholesterol efflux as a measure of HDL functionality in humans: impact of genetics, diet and weight loss Charlotte P.J. Talbot The studies presented in this thesis were performed within NUTRIM School of

More information

Moh Tarek + Suhayb. Tamara Al-Azzeh + Asmaa Aljeelani ... Faisal

Moh Tarek + Suhayb. Tamara Al-Azzeh + Asmaa Aljeelani ... Faisal 28 Moh Tarek + Suhayb Tamara Al-Azzeh + Asmaa Aljeelani... Faisal Digestion of dietary lipids Lipid digestion and absorption are complex processes. They involve soluble enzymes, substrates with different

More information

A Study of Omega-3 Fatty Acid. Therapy in Patients with. Nephrotic Syndrome

A Study of Omega-3 Fatty Acid. Therapy in Patients with. Nephrotic Syndrome A Study of Omega-3 Fatty Acid Therapy in Patients with Nephrotic Syndrome Dr Samira Siddiqui Renal Unit Glasgow Royal Infirmary Thesis for the degree of MD, Faculty of Medicine, University of Glasgow Submitted

More information

High density lipoprotein metabolism

High density lipoprotein metabolism High density lipoprotein metabolism Shlomo Eieenberg Lipid Research Laboratory, Department of Medicine B, Hadassah University Hospital, Jerusalem, Israel 1. INTRODUCTION Interest in high density lipoproteins

More information

Hyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi

Hyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi Hyperlipidemia Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi Outline The story of lipids Definition of hyperlipidemia Classification of hyperlipidemia Causes of hyperlipidemia

More information

CHAPTER 1. General Introduction

CHAPTER 1. General Introduction CHAPTER 1 General Introduction General Introduction Contents 1. Lipoproteins and lipid metabolism 1. Exogenous pathway 2. Endogenous pathway 3. Reverse cholesterol pathway 2. Atherosclerosis 1. Pathogenesis

More information

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids: CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation

More information

Reverse Cholesterol Transport and Atherosclerosis

Reverse Cholesterol Transport and Atherosclerosis JCR2014 (2014.12.13@Novotel, Busan, South Korea) Reverse Cholesterol Transport and Atherosclerosis Shizuya Yamashita, MD, PhD, FAHA, FJCC Department of Community Medicine Department ofcardiovascular Medicine

More information

Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins

Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins 1070 Biochemical Society Transactions (2003) Volume 31, part 5 Relevance of hepatic lipase to the metabolism of triacylglycerol-rich lipoproteins A. Zambon 1,S.Bertocco, N. Vitturi, V. Polentarutti, D.

More information

PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL

PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL Lipids are characterized by low polarity and limited solubility in water. Their plasma concentration is about 500-600

More information

ANTIHYPERLIPIDEMIA. Darmawan,dr.,M.Kes,Sp.PD

ANTIHYPERLIPIDEMIA. Darmawan,dr.,M.Kes,Sp.PD ANTIHYPERLIPIDEMIA Darmawan,dr.,M.Kes,Sp.PD Plasma lipids consist mostly of lipoproteins Spherical complexes of lipids and specific proteins (apolipoproteins). The clinically important lipoproteins, listed

More information

METABOLISM of ADIPOSE TISSUE

METABOLISM of ADIPOSE TISSUE METABOLISM of ADIPOSE TISSUE 2. LF UK Prof. Rudolf Poledne, PhD. TYPES OF ADIPOSE TISSUE brown adipose tissue subcutaneous adipose tissue visceral adipose tissue ADIPOSE TISSUE FUNCTIONS: thermal isolation

More information

Lipidaholics Anonymous Case 2012;13:(1);284 Explaining the unexplainable LDL- P

Lipidaholics Anonymous Case 2012;13:(1);284 Explaining the unexplainable LDL- P 1 Lipidaholics Anonymous Case 2012;13:(1);284 Explaining the unexplainable LDL- P A respected cardiologist contacted me about the following dilemma. He has a primary prevention case which is a woman with

More information

Suppl. Table 1: CV of pooled lipoprotein fractions analysed by ESI-MS/MS

Suppl. Table 1: CV of pooled lipoprotein fractions analysed by ESI-MS/MS Supplement VLDL LDL HDL PC 3.3 1.77 1.3 LPC 4.82 2.5.35 SM 3.1 4.6 1.92 CER 2.17 6.3 4.15 PE 3.18 1.93 2.79 PE-pl 13.18 1.9 2.32 CE 2.9.65.4 FC.36 3.5 2.54 Suppl. Table 1: CV of pooled lipoprotein fractions

More information

Reduction in Serum Lecithin:Cholesterol Acyltransferase Activity Prior to the Occurrence of Ketosis and Milk Fever in Cows

Reduction in Serum Lecithin:Cholesterol Acyltransferase Activity Prior to the Occurrence of Ketosis and Milk Fever in Cows FULL PAPER Biochemistry Reduction in Serum Lecithin:Cholesterol Acyltransferase Activity Prior to the Occurrence of Ketosis and Milk Fever in Cows Hisami NAKAGAWA-UETA 1) and Norio KATOH 2) * 1) Ishikawa

More information

Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID?

Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Update On Diabetic Dyslipidemia: Who Should Be Treated With A Fibrate After ACCORD-LIPID? Karen Aspry, MD, MS, ABCL, FACC Assistant Clinical Professor of Medicine Warren Alpert Medical School of Brown

More information

INTERNATIONAL JOURNAL OF BIOASSAYS ISSN: X CODEN: IJBNHY OPEN ACCESS

INTERNATIONAL JOURNAL OF BIOASSAYS ISSN: X CODEN: IJBNHY OPEN ACCESS ORIGINAL RESEARCH ARTICLE A CLINICAL STUDY OF DYSLIPIDEMIA IN PATIENTS OF CHRONIC KIDNEY DISEASE Gourav Garg 1, Sumit Pal Singh Chawla 2 * and Sarabjot Kaur 2 1 Department of Medicine, Government Medical

More information

Cellular control of cholesterol. Peter Takizawa Department of Cell Biology

Cellular control of cholesterol. Peter Takizawa Department of Cell Biology Cellular control of cholesterol Peter Takizawa Department of Cell Biology Brief overview of cholesterol s biological role Regulation of cholesterol synthesis Dietary and cellular uptake of cholesterol

More information

Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins

Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins Review Article Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins A. R. Tall From the Division of Molecular Medicine, Department

More information

Thematic review series: The Immune System and Atherogenesis

Thematic review series: The Immune System and Atherogenesis thematic review Thematic review series: The Immune System and Atherogenesis Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? Alan Chait, 1 Chang Yeop Han, John

More information

*Address Correspondence to Päivi Pajukanta, MD, PhD, Associate Professor, Department of

*Address Correspondence to Päivi Pajukanta, MD, PhD, Associate Professor, Department of Genetic Causes of High and Low Serum HDL-cholesterol Daphna Weissglas-Volkov 1 and Päivi Pajukanta 1 1 Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California, United

More information

The Role of Apolipoprotein CIII in Coronary Artery Disease. Disclosures

The Role of Apolipoprotein CIII in Coronary Artery Disease. Disclosures Miami Cardiac & Vascular Institute Cardiovascular Disease Prevention 15th Annual Symposium February 16, 2017 Nobu Eden Roc Hotel, Miami Beach, Florida. The Role of Apolipoprotein CIII in Coronary Artery

More information

Anti Hyperlipidemic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Anti Hyperlipidemic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anti Hyperlipidemic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Lipoproteins Macromolecular complexes in the blood that transport lipids Apolipoproteins

More information

LIPIDS OF BLOODSTREAM

LIPIDS OF BLOODSTREAM HEC No. 1428 ISSN No. 1681-5491 CARDIOLOGY MEDICAL CHANNEL Vol. 15, No. 2 APRIL - JUNE 2009 EDITORIAL LIPIDS OF BLOODSTREAM 1. ZAFAR ALAM MAHMOOD 2. SYED WASEEMUDDIN AHMED 3. MOHAMMAD SUALEH 4. SAAD BIN

More information

LIPID METABOLISM. Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI

LIPID METABOLISM. Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI LIPID METABOLISM Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI Lipid metabolism is concerned mainly with fatty acids cholesterol Source of fatty acids from dietary fat de novo

More information

Introduction REVIEW. M. John Chapman*, Wilfried Le Goff, Maryse Guerin, and Anatol Kontush. Keywords

Introduction REVIEW. M. John Chapman*, Wilfried Le Goff, Maryse Guerin, and Anatol Kontush. Keywords European Heart Journal (2010) 31, 149 164 doi:10.1093/eurheartj/ehp399 REVIEW Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin,

More information

Metabolism and Protective Properties of HDL

Metabolism and Protective Properties of HDL Metabolism and Protective Properties of HDL A riddle wrapped in a mystery inside an enigma Jacques Genest MD Cardiovascular Research Laboratories McGill University Health Center Disclosure J. Genest MD

More information

Lipids Board Review. Ira Goldberg, MD New York University School of Medicine. Which of the following is the best initial therapy choice?

Lipids Board Review. Ira Goldberg, MD New York University School of Medicine. Which of the following is the best initial therapy choice? Lipids Board Review Ira Goldberg, MD New York University School of Medicine 1. A 22 year old male college student is referred for severe hypertriglyceridemia ( 1500 mg/dl [ 17.0 mmol/l]). He has a history

More information

CHM333 LECTURE 34: 11/30 12/2/09 FALL 2009 Professor Christine Hrycyna

CHM333 LECTURE 34: 11/30 12/2/09 FALL 2009 Professor Christine Hrycyna Lipid Metabolism β-oxidation FA Acetyl-CoA Triacylglycerols (TAGs) and glycogen are the two major forms of stored energy in vertebrates Glycogen can supply ATP for muscle contraction for less than an hour

More information

The Addition of Ezetimibe to Statin therapy in. Patients with Homozygous Familial. Hypercholesterolaemia

The Addition of Ezetimibe to Statin therapy in. Patients with Homozygous Familial. Hypercholesterolaemia The Addition of Ezetimibe to Statin therapy in Patients with Homozygous Familial Hypercholesterolaemia Submitted in fulfilment with the requirements for the degree Master in Medicine (MMed) Dr Adriano

More information

Glossary For TheFatNurse s For All Ages Series Apolipoprotein B (APOB or ApoB) are the primary apolipoproteins of chylomicrons and low-density lipoproteins (LDL - known commonly by the misnomer "bad cholesterol"

More information

By: Dr Hadi Mozafari 1

By: Dr Hadi Mozafari 1 Biological lipids are a chemically diverse group of compounds, the common and defining feature of which is their insolubility in water. By: Dr Hadi Mozafari 1 Fats and oils are the principal stored forms

More information

Central role of apociii

Central role of apociii University of Copenhagen & Copenhagen University Hospital Central role of apociii Anne Tybjærg-Hansen MD DMSc Copenhagen University Hospital and Faculty of Health and Medical Sciences, University of Copenhagen,

More information

Introduction Hyperlipidemia hyperlipoproteinemia Primary hyperlipidemia (Familial) Secondary hyperlipidemia (Acquired)

Introduction Hyperlipidemia hyperlipoproteinemia Primary hyperlipidemia (Familial) Secondary hyperlipidemia (Acquired) Introduction Hyperlipidemia, or hyperlipoproteinemia, is the condition of abnormally elevated levels of any or all lipids and/or lipoproteins in the blood. Hyperlipidemias are divided in primary and secondary

More information

Lipoprotein Particle Profile

Lipoprotein Particle Profile Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular

More information

Plasma lipid transfer proteins

Plasma lipid transfer proteins Plasma lipid transfer proteins Alan R. Tall Department of Medicine, College of Physicians and Surgeons of Columbia University, 630 West 168th Street, New York, NY 10032 Introduction The composition of

More information

Metabolic defects underlying dyslipidemia in abdominal obesity

Metabolic defects underlying dyslipidemia in abdominal obesity Metabolic defects underlying dyslipidemia in abdominal obesity Professor Marja-Riitta Taskinen Department of Medicine, Division of Cardiology Helsinki University Hospital, Finland Disclosures: Honorariums/

More information

Alow level of HDL cholesterol is an important cardiovascular

Alow level of HDL cholesterol is an important cardiovascular High Density Lipoproteins and Arteriosclerosis Role of Cholesterol Efflux and Reverse Cholesterol Transport Arnold von Eckardstein, Jerzy-Roch Nofer, Gerd Assmann Abstract High density lipoprotein (HDL)

More information

Thematic Review Series: Genetics of Human Lipid Diseases. Genetic causes of high and low serum HDL-cholesterol

Thematic Review Series: Genetics of Human Lipid Diseases. Genetic causes of high and low serum HDL-cholesterol thematic review Thematic Review Series: Genetics of Human Lipid Diseases Genetic causes of high and low serum HDL-cholesterol Daphna Weissglas-Volkov and Päivi Pajukanta 1 Department of Human Genetics,

More information